The role of antibiotics in acute exacerbations of chronic obstructive pulmonary disease

Current Infectious Disease Reports

Volumn 5, Issue 1, 2003, Pages 9-15

  Sethi, Sanjay ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; GEMIFLOXACIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HEALTH CARE QUALITY; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LUNG FUNCTION; LUNG LAVAGE; MOLECULAR MECHANICS; MORAXELLA CATARRHALIS; PATHOGENESIS; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 1642351886     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-003-0059-x     Document Type: Review

References (32)

1. Hirschmann JV: Do bacteria cause exacerbations of COPD? Chest 2000, 118:193-203.
2. Murphy TF, Sethi S, Niederman MS: The role of bacteria in exacerbations of COPD. A constructive view. Chest 2000, 118:204-209.
3. Sethi S: Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000, 117:380S-385S.
4. Tager I, Speizer FE: Role of infection in chronic bronchitis. N Engl J Med 1975, 292:563-571.
5. Murphy TF, Sethi S: Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992, 146:1067-1083.
6. Isada CM: Pro: Antibiotics for chronic bronchitis with exacerbations. Semin Respir Infect 1993, 8:243-253.
7. Nicona MB Kronenberg S: Con: antibiotic use in exacerbations of chronic bronchitis. Semin Respir Infect 1993, 8:254-258.
8. Smith CB, Golden C, Klauber MR, et al.: Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976, 134:552-561.
9. Gump DW, Phillips CA, Forsyth BR, et al.: Role of infection in chronic bronchitis. Am Rev Respir Dis 1976, 113:465-473.
10. Saint S, Bent S, Vittinghoff E, et al.: Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 1995, 273:957-966.
11. Sethi S, Murphy TF: Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001, 14:336-363.
12. Fagon J-Y, Chastre J, Trouillet J-L, et al.: Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis 1990, 142:1004-1008.
13. Monso E, Ruiz J, Rosell A, et al.: Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995, 152:1316-1320.
14. Pela R, Marchesani F, Agostinelli C, et al.: Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch Chest Dis 1998, 53:262-267.
15. Soler N, Torres A, Ewig S, et al.: Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998, 157:1498-1505.
16. Sethi S, Muscarella K, Evans N, et al.: Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000, 118:1557-1565.
17. Gompertz S, O'Brien C, Bayley DL, et al.: Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001, 17:1112-1119.
18. Yi K, Sethi S, Murphy T: Human immune response to non-typeable Haemophilus influenzae in chronic bronchitis. J Infect Dis 1997, 176:1247-1252.
19. Bakri F, Brauer AL, Sethi S, et al.: Systemic and mucosal antibody response to Moraxella catarrhalis following exacerbations of chronic obstructive pulmonary disease. J Infect Dis 2002, 185:632-640.
20. Sethi S, Evans N, Grant BJB, et al.: Acquisition of a new bacterial strain and occurrence of exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465-471.
21. Howard P: A long-term follow-up of respiratory symptoms and ventilatory function in a group of working men. Br J Industr Med 1970, 27:326-333.
22. Bates DV: The fate of the chronic bronchitic: a report of the ten-year follow-up in the Canadian Department of Veteran's Affairs coordinated study of chronic bronchitis. Am Rev Respir Dis 1973, 108:1043-1065.
23. Fletcher F, Peto R: Natural history of chronic airflow obstruction. Br Med J 1977, 13:1645-1648.
24. Howard P: Evolution of the ventilatory capacity in chronic bronchitis. Br Med J 1967, 3:392-395.
25. Kanner R, Renzetti AD Jr, Klauber MR, et al.: Variables associated with changes in spirometry in patients with obstructive lung diseases. Am J Med 1979, 67:44-50.
26. Kanner R, Anthonisen NR, Connett JE, et al.: Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001, 164:358-364.
27. Seemungal TAR, Donaldson GC, Bhowmik A, et al.: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1608-1613.
28. Laurenzi GA, Potter RT, Kass EH: Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961, 265:1273-1278.
29. Khair OA, Davies RJ, Devalia JL: Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996, 9:1913-1922.
30. Soler N, Ewig S, Torres A, et al.: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999, 14:1015-1022.
31. Wilson R, Schentag JJ, Ball P, Mandell L: A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther 2002, 24:639-652.
32. Jones PW Spencer S, on behalf of the GLOBE Study Group: Patients with recurrent AECB have poorer health and recover more slowly and less completely after an acute episode: the GLOBE study. Paper present at 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto. September 17-20, 2000.